Skip to Main Content

Paper Details

Bringing Stem Cell-Based Therapies for Type 1 Diabetes to the Clinic: Early Insights from Bioprocess Economics and Cost-Effectiveness Analysis.
Biotechnol J
12
2019
Author NameAffiliation
Stan N FinkelsteinDivision of Clinical Informatics, Beth Israel Deaconess Medical Center
Stan N FinkelsteinInstitute for Data, Massachusetts Institute of Technology
  • 1 - 2

Datasets

Release 1.2